We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

383 hedge funds and large institutions have $8.87B invested in United Therapeutics in 2015 Q2 according to their latest regulatory filings, with 70 funds opening new positions, 132 increasing their positions, 138 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more call options, than puts

Call options by funds: $64.9M | Put options by funds: $40M

43% more first-time investments, than exits

New positions opened: 70 | Existing positions closed: 49

5% more funds holding

Funds holding: 366 → 383 (+17)

2% less capital invested

Capital invested by funds: $9.02B → $8.87B (-$146M)

4% less repeat investments, than reductions

Existing positions increased: 132 | Existing positions reduced: 138

33% less funds holding in top 10

Funds holding in top 10: 15 → 10 (-5)

Holders
383
Holders Change
+17
Holders Change %
+4.64%
% of All Funds
10.32%
Holding in Top 10
10
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-33.33%
% of All Funds
0.27%
New
70
Increased
132
Reduced
138
Closed
49
Calls
$64.9M
Puts
$40M
Net Calls
+$24.9M
Net Calls Change
-$9.86M

Top Buyers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
+$92.2M
2
Renaissance Technologies
Renaissance Technologies
New York
+$65.7M
3
Deutsche Bank
Deutsche Bank
Germany
+$59M
4
Invesco
Invesco
Georgia
+$57.9M
5
First Trust Advisors
First Trust Advisors
Illinois
+$56.4M

Top Sellers

Rank Fund Capital Flow
1
TCM
TimesSquare Capital Management
New York
-$140M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$134M
3
LSV Asset Management
LSV Asset Management
Illinois
-$116M
4
YCMGA
York Capital Management Global Advisors
New York
-$64.2M
5
CCM
Consonance Capital Management
New York
-$58.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
SGAM
51
Smith Group Asset Management
Texas
$34.8M -$5.47M -30,380 -13%
ACM
52
Apex Capital Management
Ohio
$32.9M +$1.66M +9,234 +5%
Dimensional Fund Advisors
53
Dimensional Fund Advisors
Texas
$32.7M +$762K +4,236 +2%
WG
54
Winton Group
United Kingdom
$32.2M +$5.22M +29,040 +19%
JP Morgan Chase
55
JP Morgan Chase
New York
$32.2M -$3.9M -21,675 -10%
PPA
56
Parametric Portfolio Associates
Washington
$30.8M -$607K -3,376 -2%
SAM
57
Sectoral Asset Management
Quebec, Canada
$30.6M +$126K +700 +0.4%
California Public Employees Retirement System
58
California Public Employees Retirement System
California
$28.4M -$13.1M -72,642 -31%
Neuberger Berman Group
59
Neuberger Berman Group
New York
$26.9M -$1.74M -9,689 -6%
KAM
60
Krensavage Asset Management
New York
$25.9M +$3.25M +18,057 +14%
MCM
61
Maryland Capital Management
Maryland
$25.4M +$145K +805 +0.6%
Principal Financial Group
62
Principal Financial Group
Iowa
$24.7M +$730K +4,060 +3%
Federated Hermes
63
Federated Hermes
Pennsylvania
$24.4M -$2.62M -14,564 -9%
BC
64
Burney Company
Virginia
$23.5M -$1.34M -7,469 -5%
RCAMU
65
Rothschild & Co Asset Management US
Connecticut
$23.2M -$7.21M -40,074 -23%
Charles Schwab
66
Charles Schwab
California
$22.9M +$1.43M +7,934 +6%
VanEck Associates
67
VanEck Associates
New York
$21.7M +$1.4M +7,802 +7%
Millennium Management
68
Millennium Management
New York
$21.6M -$18.5M -102,711 -45%
AIMCA
69
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$21.5M +$1.49M +8,300 +7%
CEP
70
Chicago Equity Partners
Illinois
$21.1M -$2.29M -12,710 -9%
FCM
71
Frontier Capital Management
Massachusetts
$20.9M -$15.8M -87,734 -42%
Ameriprise
72
Ameriprise
Minnesota
$20.9M -$13.4M -74,487 -38%
Sumitomo Mitsui Trust Group
73
Sumitomo Mitsui Trust Group
Japan
$20.8M +$21.5M +119,416 New
Wellington Management Group
74
Wellington Management Group
Massachusetts
$20.6M +$1.83M +10,148 +9%
NAP
75
New Amsterdam Partners
New York
$20.5M +$665K +3,696 +3%
1 2
3
4 5

UTHR Hedge Fund Activity: Q2 2015 in Review

383 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q2 2015, worth a combined $8.87B — down 1.6% from $9.02B a quarter earlier.

Buyers outnumbered sellers: 70 funds opened new UTHR positions and 49 closed out — a net gain of 21 holders — while 132 added to existing stakes and 138 trimmed.

The largest buyer was Putnam Investments, adding an estimated $92.2M. The largest seller was TimesSquare Capital Management, cutting an estimated $140M.

  • 383 institutional investors held United Therapeutics (UTHR) as of Q2 2015, up from 366 in Q1 2015.
  • Funds reported $8.87B of United Therapeutics stock for Q2 2015, down 1.6% quarter-over-quarter.
  • 70 funds opened new United Therapeutics positions in Q2 2015 and 49 closed out, a net change of +21 holders.
  • The largest United Therapeutics buyer in Q2 2015 was Putnam Investments, an estimated $92.2M added.
  • The largest United Therapeutics seller in Q2 2015 was TimesSquare Capital Management, an estimated $140M sold.

Based on aggregated 13F filings for Q2 2015.